With this issue, the Journal of Thoracic Imaging inaugurates a new feature entitled “Current Controversies in Cardiothoracic Imaging.” Articles published in prestigious peer-reviewed journals such as JTI undergo rigorous screening and review before acceptance. This may foster the impression that for any particular research or clinical imaging issue there is a single settled answer. In fact, in many instances, important questions related to cardiothoracic imaging remain unresolved and subject to differing interpretations of the data. Thus, the purpose of “Current Controversies in Cardiothoracic Imaging” is to highlight and promote discussion of areas of uncertainty in our field.
The format of the series is straightforward. Two experts in cardiothoracic imaging are selected to provide the “pro” and “con” perspectives of a contentious topic. Their articles are not intended to be an exhaustive review of the literature but rather a concise and relevant discussion of the background of the controversy and a well-reasoned opinion as to why the expert supports his or her particular side of the controversy. The first installment of the series features a debate on the important question of whether substantial overdiagnosis of pulmonary embolism is occurring with the use of CT pulmonary angiography (CTPA). Our experts are, Dr Linda Haramati and Dr Martine Remy-Jardin, both of whom have contributed extensively to the literature on CTPA. Drs Haramati and Remy-Jardin discuss, respectively, the “pro” and “con” sides of the CTPA overdiagnosis controversy.1,2 Upcoming articles in this series will highlight other hot-button topics. We hope you will find the “Controversies in Cardiothoracic Imaging” to be both enjoyable and informative.
1. Tan S, Haramati LB. Are we overdiagnosing pulmonary embolism? Yes! Paradigm shift in pulmonary embolism. J Thorac Imaging. 2018;33:346–347.
2. Remy-Jardin M. Are we overdiagnosing pulmonary embolism? No! J Thorac Imaging. 2018;33:348–349.